Polymeric micelles for pH-responsive delivery of cisplatin

Abstract Methoxy poly(ethylene oxide)-block-poly-(α-carboxylate-ε-caprolactone) (PEO-b-PCCL) was used to develop pH-responsive polymeric micelles for the delivery of cisplatin (CDDP). Micelles were prepared through complexation of CDDP with the pendant carboxyl groups on the poly(ε-caprolactone) core, perhaps through coordinate bonding. The obtained micelles were characterized using dynamic light scattering (DLS) measurement for size and stability. The in vitro release of CDDP at different pHs (7.4, 6.0 and 5.0) was evaluated. The in vitro cell uptake as well as cytotoxicity of developed micelles against two breast cancer cell lines, i.e. MDA-MB-435 and MDA-MB-231, were also assessed and compared to free CDDP as control. DLS results showed PEO-b-PCCL to form stable micelles with an average diameter of <50 nm upon complexation with CDDP. Developed polymeric micelles were capable of slowly releasing CDDP in physiological pH. However, CDDP release from polymeric micelles was triggered upon exposure to electrolytes and/or acidic pHs mimicking that of extracellular tumor microenvironment or intracellular organelles. Consistent with the slow release of CDDP from its polymeric micellar formulation, polymeric micellar CDDP exhibited lower cytotoxicity and CDDP intracellular uptake compared to free drug. The results indicate a great potential for the developed formulation in platinum therapy of breast cancer.

[1]  M. Hung,et al.  The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines , 2010, Breast cancer : basic and clinical research.

[2]  S. Lipkowitz,et al.  Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. , 2010, Breast disease.

[3]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[4]  Gert Storm,et al.  Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release , 2010, Pharmaceutical Research.

[5]  Y. Sugiyama,et al.  Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. , 2003, Cancer research.

[6]  Xiao-bing Xiong,et al.  Novel Self-Associating Poly(ethylene oxide)-block-poly(ε-caprolactone) Block Copolymers with Functional Side Groups on the Polyester Block for Drug Delivery , 2006 .

[7]  Afsaneh Lavasanifar,et al.  Polymeric micelles for drug delivery , 2006, Expert opinion on drug delivery.

[8]  M. Ladomery,et al.  Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells. , 2013, International journal of oncology.

[9]  N. Nishiyama,et al.  Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats , 2005, British Journal of Cancer.

[10]  C. Giandomenico,et al.  Current Status of Platinum-Based Antitumor Drugs , 1999 .

[11]  Xiao-bing Xiong,et al.  Polymeric micelles for drug targeting , 2007, Journal of drug targeting.

[12]  V. Leblanc,et al.  Cisplatin increases B‐cell‐lymphoma‐2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells , 2012, International journal of cancer.

[13]  Kazunori Kataoka,et al.  Block copolymer micelles as long-circulating drug vehicles , 1995 .

[14]  L. Marky,et al.  Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum(II). , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[15]  A. Pineda-Lucena,et al.  Polymer conjugates as therapeutics: future trends, challenges and opportunities. , 2008, Expert opinion on drug delivery.

[16]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  S. Miller,et al.  Nanomedicine in chemoradiation. , 2013, Therapeutic delivery.

[18]  D. Osella,et al.  Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS). , 2004, Journal of inorganic biochemistry.

[19]  Hans-Peter Lipp,et al.  Toxicity of platinum compounds , 2003, Expert opinion on pharmacotherapy.

[20]  Sonke Svenson,et al.  Dendrimers as versatile platform in drug delivery applications. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[22]  Y. Matsumoto,et al.  Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[23]  W. Gispen,et al.  Neurotoxic side-effects of cisplatin. , 1991, European journal of cancer.

[24]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[25]  Z. Szallasi,et al.  Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  S. Zalba,et al.  Liposomes, a promising strategy for clinical application of platinum derivatives , 2013, Expert opinion on drug delivery.

[27]  M. Ro̸rth,et al.  Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose , 2004, Cancer Chemotherapy and Pharmacology.

[28]  H. Uludaǧ,et al.  Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. , 2009, Biomaterials.

[29]  P. Catalano,et al.  Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Jones,et al.  Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  Rachel A. Kudgus,et al.  Intrinsic Therapeutic Applications of Noble Metal Nanoparticles: Past, Present and Future , 2012 .

[32]  Yitao Wang,et al.  Polymeric micelles drug delivery system in oncology. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Zijian Guo,et al.  Targeting and Delivery of Platinum-Based Anticancer Drugs , 2013 .

[34]  M. Winnik,et al.  Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers , 1990 .

[35]  S. Kellie,et al.  SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE , 2005, Pediatric hematology and oncology.

[36]  Y. Matsumura.  Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. , 2008, Advanced drug delivery reviews.

[37]  Xiao-bing Xiong,et al.  Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[38]  Ehud Segal,et al.  Design and development of polymer conjugates as anti-angiogenic agents. , 2009, Advanced drug delivery reviews.

[39]  K. Nugent,et al.  Cisplatin Nephrotoxicity: A Review , 2007, The American journal of the medical sciences.

[40]  H. Reile,et al.  Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation , 2004, Cancer Chemotherapy and Pharmacology.

[41]  Pramod Kumar,et al.  Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy. , 2012, Critical reviews in therapeutic drug carrier systems.

[42]  Supriya Shidhaye,et al.  Advances in polymeric micelles for drug delivery and tumor targeting. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[43]  Y. Matsumura.  Polymeric micellar delivery systems in oncology. , 2008, Japanese journal of clinical oncology.

[44]  A. Boddy,et al.  A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours , 2011, British Journal of Cancer.